ArticleCurrent biology : CB2026
A lipid-binding protein that boosts daytime wake is mainly located at the body surface and blocks light-induced lipid peroxidation in the brain.
Article in Current biology : CB, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
We report a previously unrecognized brain vulnerability from visible-light exposure that is exacerbated by high-fat diets (HFDs). Prior work in Drosophila identified daywake (dyw), a predicted lipid/hormone-binding protein that stimulates wakefulness only when animals are exposed to visible light. Herein, we show that HFDs preferentially increase daytime sleep in dyw-null flies compared with wild-type flies, consistent with dyw's strong inducibility by HFD. This increased daytime sleep is causally linked to light-dependent reactive oxygen species (ROS) accumulation and lipid peroxidation at the blood-brain barrier (BBB) and cortex region of the brain, events which are eliminated by a return to darkness or dietary supplements with antioxidants. Although DYW is not detected in the brain, it is produced in thousands of sensory neurons at or near the body surface where it also blocks light-dependent lipid peroxidation. Our studies implicate the BBB as a key redox sensor linking peripheral oxidative stress to wake-sleep control. The potential toxicity from elevated brain ROS production due to increased neuronal activity during wakefulness is thought to be mainly cleared during nighttime sleep. We propose an additional adaptation for day-active life forms whereby antioxidant activity at the body surface limits the risk of visible-light exposure from triggering systemic increases in the levels of ROS and lipid peroxidation, thus lowering overall oxidative burden in the brain and, hence, the ability of visible light to safely stimulate enhanced wakefulness states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.